Published in Sante Ment Que on January 01, 2005
Integrated psychological therapy (IPT) for schizophrenia: is it effective? Schizophr Bull (2006) 1.29
Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull (2011) 0.96
Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22
An adaptation of the theory of interpersonal behaviour to the study of telemedicine adoption by physicians. Int J Med Inform (2003) 2.15
Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. J Clin Psychiatry (2007) 2.13
Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care (2013) 2.08
Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am J Psychiatry (2009) 1.95
The research collective: a tool for producing timely, context-linked research syntheses. Healthc Policy (2006) 1.74
Nature and prevalence of mental illness in the workplace. Healthc Pap (2004) 1.58
Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression. J Clin Psychiatry (2007) 1.58
The crossover approach to switching antipsychotics: what is the evidence? Schizophr Res (2005) 1.55
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. Schizophr Res (2008) 1.48
An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord (2006) 1.44
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf (2012) 1.42
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull (2004) 1.31
Service use for mental health reasons: cross-provincial differences in rates, determinants, and equity of access. Can J Psychiatry (2005) 1.30
Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv (2007) 1.17
Life trajectories and burden of adversity: mapping the developmental profiles of suicide mortality. Psychol Med (2007) 1.17
Characterization of impulsivity in suicide completers: clinical, behavioral and psychosocial dimensions. J Affect Disord (2006) 1.15
Family physician involvement in cancer care follow-up: the experience of a cohort of patients with lung cancer. Ann Fam Med (2010) 1.12
Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation. BMJ (2009) 1.12
Patients' perceptions of the quality of care after primary care reform: Family medicine groups in Quebec. Can Fam Physician (2010) 1.12
Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Can J Psychiatry (2008) 1.09
Joint effect of depression and chronic conditions on disability: results from a population-based study. Psychosom Med (2007) 1.08
Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res (2004) 1.07
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. J Clin Psychiatry (2011) 1.06
Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry (2007) 1.06
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Housing for persons with serious mental illness: consumer and service provider preferences. Psychiatr Serv (2008) 1.05
Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophr Res (2004) 1.04
Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res (2005) 1.04
Family physicians and psychiatrists. Qualitative study of physicians' views on collaboration. Can Fam Physician (2002) 1.04
Involving decision-makers in producing research syntheses: the case of the research collective on primary healthcare in quebec. Healthc Policy (2007) 1.02
Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion (2004) 1.02
Patient, primary care physician and specialist expectations of primary care physician involvement in cancer care. J Gen Intern Med (2011) 1.02
Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study. J Psychiatry Neurosci (2002) 1.01
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry (2007) 1.01
Mental health network governance: comparative analysis across Canadian regions. Int J Integr Care (2010) 1.01
CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn (2005) 1.00
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. Schizophr Res Treatment (2012) 1.00
Predictors of quality of life in schizophrenia. Community Ment Health J (2005) 1.00
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci (2007) 0.99
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res (2007) 0.98
Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophr Res (2003) 0.98
Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: a randomized study. Schizophr Res (2009) 0.97
Telehealth adoption in hospitals: an organisational perspective. J Health Organ Manag (2005) 0.96
Use of administrative data for the surveillance of mental disorders in 5 provinces. Can J Psychiatry (2009) 0.96
Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2014) 0.95
The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Can J Psychiatry (2004) 0.94
Mental disorders and mental health care in Canada and Australia: comparative epidemiological findings. Soc Psychiatry Psychiatr Epidemiol (2008) 0.94
Public telesurveillance service for frail elderly living at home, outcomes and cost evolution: a quasi experimental design with two follow-ups. Health Qual Life Outcomes (2006) 0.94
Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf (2008) 0.93
Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. Psychiatry Res (2005) 0.92
Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates. Soc Psychiatry Psychiatr Epidemiol (2011) 0.92
STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry (2005) 0.92
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology (Berl) (2003) 0.92
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers. Schizophr Res (2002) 0.91
Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings. BMC Pregnancy Childbirth (2003) 0.91
Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain Cogn (2005) 0.90
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. J Psychiatr Res (2008) 0.90
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
ERP investigation of study-test background mismatch during face recognition in schizophrenia. Schizophr Res (2011) 0.89
Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet (2003) 0.89
Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Curr Med Res Opin (2007) 0.89
Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Rev Neurother (2011) 0.89
Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities. Eur J Hum Genet (2010) 0.89
Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Med (2012) 0.88
General practice and mental health care: determinants of outpatient service use. Can J Psychiatry (2009) 0.88
Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Can J Psychiatry (2007) 0.88
Should psychological distress screening in the community account for self-perceived health status? Can J Psychiatry (2009) 0.88
Mortality associated with depression: a forty-year perspective from the Stirling County Study. Soc Psychiatry Psychiatr Epidemiol (2008) 0.88
Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. Int Clin Psychopharmacol (2011) 0.88
Suicide and no axis I psychopathology. BMC Psychiatry (2004) 0.88
Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal. Psychiatry Res (2011) 0.87
Patients' report of help provided by relatives and services to meet their needs. Community Ment Health J (2008) 0.87
Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment. J Clin Psychopharmacol (2005) 0.87
Suicide cases in New Brunswick from April 2002 to May 2003: the importance of better recognizing substance and mood disorder comorbidity. Can J Psychiatry (2006) 0.87
Agenesis of corpus callosum and emotional information processing in schizophrenia. Front Psychiatry (2012) 0.87
Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Res (2010) 0.87
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis. Clin Schizophr Relat Psychoses (2013) 0.86
Spatio-temporal clustering of the incidence of schizophrenia in Quebec, Canada from 2004 to 2007. Spat Spatiotemporal Epidemiol (2013) 0.86